Conese M, Blasi F
Department of Genetics and Microbial Biology, University of Milano, Italy.
Biol Chem Hoppe Seyler. 1995 Mar;376(3):143-55.
The urokinase-type plasminogen activator (uPA) is secreted as a single-chain inactive zymogen (pro-uPA). Upon its secretion, pro-uPA binds to its glycosylphosphatidylinositol-anchored specific cell receptor (uPAR). The activation of pro-uPA to the active two-chain uPA is accelerated with uPAR-bound pro-uPA and is achieved by plasmin and proteases of other classes like cathepsins G and L. uPAR-bound uPA is susceptible to inhibition by its specific inhibitors (PAI-1, PAI-2, and PN-1). uPA-PAI-1 and uPA-PN-1 complexes, but not free uPA, are readily internalized and degraded through a mechanism that involves the multiligand receptors alpha 2-macroglobulin receptor/low density lipoprotein receptor-associated protein (alpha 2-MR) and epithelial glycoprotein 330 (gp330). Upon uPA-inhibitor internalization, uPAR is itself endocytosed and recycled back to the cell surface. PMA-induced differentiation of myeloid cells is accompanied by inhibition of uPA-PAI-1 internalization/degradation and the down-regulation of alpha 2-MR. The regulation of uPAR and alpha 2-MR levels might be part of the differentiation program of myeloid cells.
尿激酶型纤溶酶原激活剂(uPA)以单链无活性酶原(pro-uPA)的形式分泌。分泌后,pro-uPA与其糖基磷脂酰肌醇锚定的特异性细胞受体(uPAR)结合。与uPAR结合的pro-uPA可加速其激活为活性双链uPA,这一过程由纤溶酶以及组织蛋白酶G和L等其他类别的蛋白酶完成。与uPAR结合的uPA易受其特异性抑制剂(PAI-1、PAI-2和PN-1)的抑制。uPA-PAI-1和uPA-PN-1复合物而非游离uPA,可通过涉及多配体受体α2-巨球蛋白受体/低密度脂蛋白受体相关蛋白(α2-MR)和上皮糖蛋白330(gp330)的机制被迅速内化并降解。uPA-抑制剂内化后,uPAR自身会被内吞并循环回到细胞表面。佛波酯(PMA)诱导的髓样细胞分化伴随着uPA-PAI-1内化/降解的抑制以及α2-MR的下调。uPAR和α2-MR水平的调节可能是髓样细胞分化程序的一部分。